INBRX-105 - PDL1x41BB antibody
Ph 1 Ph 2 INBRX-105
Phase 1 small_molecule terminated
Quick answer
INBRX-105 - PDL1x41BB antibody for Metastatic Solid Tumors is a Phase 1 program (small_molecule) at Inhibrx Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Inhibrx Biosciences
- Indication
- Metastatic Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated